1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Sperm count in Swedish clinical stage I testicular cancer patients following adjuvant treatment
2019) In Annals of oncology : official journal of the European Society for Medical Oncology 30(4). p.604-611(
- Contribution to journal › Article
- 2018
-
Mark
Intermediate prognosis in metastatic germ cell tumors (IPGCT) : Outcome and prognostic stratification
2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29. p.325-325(
- Contribution to journal › Article
- 2016
-
Mark
Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy : A report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)
(
- Contribution to journal › Article
- 2015
-
Mark
Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Inhibin B concentration is predictive for long-term azoospermia in men treated for testicular cancer.
(
- Contribution to journal › Article
-
Mark
One Course of Adjuvant BEP in Clinical Stage I Nonseminoma Mature and Expanded Results from the SWENOTECA group.
(
- Contribution to journal › Article
- 2013
-
Mark
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
(
- Contribution to journal › Scientific review
- 2011
-
Mark
High-dose Chemotherapy With Autologous Stem-cell Support in Patients With Metastatic Non-seminomatous Testicular Cancer - a Report From the Swedish Norwegian Testicular Cancer Group (SWENOTECA)
2011) European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care In European Journal of Cancer 47. p.507-508(
- Contribution to journal › Published meeting abstract
- 2010
-
Mark
Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study
(
- Contribution to journal › Article
- 2009
-
Mark
Individualized intensification of treatment based on tumor marker decline in metastatic nonseminomatous germ cell testicular cancer (NSGCT): A report from the Swedish Norwegian Testicular Cancer Group, SWENOTECA
2009) 45th Annual Meeting of the American-Society-of-Clinical-Oncology In Journal of Clinical Oncology 27(15).(
- Contribution to journal › Published meeting abstract